BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 574982)

  • 1. Development of sequence specific radioimmunoassay of human parathyroid hormone and its use in the diagnosis of hyperparathyroidism.
    Gautvik KM; Teig V; Halvorsen JF; Arnesen E; Myhre L; Heimann P; Tollman R
    Scand J Clin Lab Invest; 1979 Sep; 39(5):469-78. PubMed ID: 574982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the molecular forms of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failure.
    Gautvik KM; Gautvik VT; Halvorsen JF
    Scand J Clin Lab Invest; 1983 Nov; 43(7):553-64. PubMed ID: 6658372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral metabolism of parathyroid hormone in patients with primary hyperparathyroidism as judged by immunological and biological studies.
    Gautvik KM; Gordeladze JO; Moxheim E; Gautvik VT
    Eur Surg Res; 1984; 16 Suppl 2():41-54. PubMed ID: 6723731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone: radioimmunoassay and clinical interpretation.
    Hawker CD
    Ann Clin Lab Sci; 1975; 5(5):383-98. PubMed ID: 1180481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region-specific immunoassays for parathyroid hormone.
    Barling PM; Hendy GN; Evans MC; O'Riordan JL
    J Endocrinol; 1975 Sep; 66(3):307-18. PubMed ID: 1194809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of a radioimmunoassay for parathyroid hormone in human serum.
    Almqvist S; Hjern B; Wästhed B
    Acta Endocrinol (Copenh); 1975 Mar; 78(3):493-509. PubMed ID: 1173015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of region specific radioimmunoassays for characterization of circulating calcitonin in patients with medullary carcinoma of the thyroid gland.
    Myhre L; Gautvik KM
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):449-61. PubMed ID: 474037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human parathyroid hormone. Immunological characterization of antibodies against a glandular extract and the synthetic amino-terminal fragments 1-12 and 1-34 and their use in the determination of immunoreactive hormone in human sera.
    Fischer JA; Binswanger U; Dietrich FM
    J Clin Invest; 1974 Dec; 54(6):1382-94. PubMed ID: 4474187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A radioimmunoassay for human parathyroid hormone utilizing a goat anti-bovine PTH serum.
    Mallette LE
    Acta Endocrinol (Copenh); 1981 Feb; 96(2):215-21. PubMed ID: 7468103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of parathyroid hormone. Clinical and physiologic implications.
    Silverman R; Yalow RS
    J Clin Invest; 1973 Aug; 52(8):1958-71. PubMed ID: 4719672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of hyperparathyroidism in patients with urolithiasis using measurement of serum immunoreactive parathyroid hormone and serum calcium.
    Kvarstein B; Gautvik K; Steinsvik E; Mathisen W
    Scand J Urol Nephrol; 1983; 17(1):105-8. PubMed ID: 6867614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism.
    Benson RC; Riggs BL; Pickard BM; Arnaud CD
    J Clin Invest; 1974 Jul; 54(1):175-81. PubMed ID: 4834887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoheterogeneity of parathyroid hormone in venous effluent serum from hyperfunctioning parathyroid glands.
    Flueck JA; Di Bella FP; Edis AJ; Kehrwald JM; Arnaud CD
    J Clin Invest; 1977 Dec; 60(6):1367-75. PubMed ID: 915003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine parathyroid hormone-(41-84), a hormone fragment with desirable properties for use as radioligand.
    Mallette LE; Bradley WA
    J Lab Clin Med; 1981 Dec; 98(6):886-95. PubMed ID: 7310228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of parathyroid hormone and its fragments on results from midregion and C-terminal specific radioimmunoassays.
    Kübler N; Krause U; Wagner PK; Beyer J; Rothmund M
    Exp Clin Endocrinol; 1987 Mar; 89(1):61-9. PubMed ID: 3595732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer.
    Riggs BL; Arnaud CD; Reynolds JC; Smith LH
    J Clin Invest; 1971 Oct; 50(10):2079-83. PubMed ID: 4330004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved diagnosis of primary hyperparathyroidism by defining the inverse relationship between serum immunoreactive parathyroid hormone and calcium.
    Halvorsen JF; Gautvik VT; Gautvik KM
    Scand J Clin Lab Invest; 1986 Sep; 46(5):435-42. PubMed ID: 3749790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid function in primary osteoporosis.
    Riggs BL; Arnaud CD; Jowsey J; Goldsmith RS; Kelly PJ
    J Clin Invest; 1973 Jan; 52(1):181-4. PubMed ID: 4734167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homologous radioimmunoassay for human carboxyl-terminal parathyroid hormone and its clinical evaluation.
    Tomita A; Yoneda M; Takano T; Uchikawa T; Takatsuki K; Katsuragi S; Noda T; Watanabe S
    Endocrinol Jpn; 1983 Oct; 30(5):585-92. PubMed ID: 6671460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay specific for amino (N) and carboxyl (C) terminal portion of parathyroid hormone.
    Tanaka M; Abe K; Adachi I; Yamaguchi K; Miyakawa S; Hirakawa H; Kumaoka S
    Endocrinol Jpn; 1975 Dec; 22(6):471-7. PubMed ID: 1231989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.